glp -1 agonist GLP-1 Agonists GLP-1 Agonists - What is

Objective To determine whether the use of glucagon-like peptide-1 (GLP-1) receptor agonists is associated with an increased risk of suicidal ideation, self-harm, and suicide among patients with type 2 diabetes compared with the use of dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter-2 (SGLT-2) inhibitors

95% CI 0.89, 0.96) and all-cause mortality rate (HR 0.70

Understand about the investigational Alluvi Retatrutide 40 mg injection a GLP-1 + GIP + Glucagon triple-agonist studied for obesity

New research suggests that switching to a maintenance dose of GLP-1 medication could help lock in weight loss.

Rita Kapoor Explain the Timeline for Appetite Suppression and Weight Loss.

and is not a GLP-1 agonist drug.**